Peter D. Eisenberg
Impact in
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 39
- Cancer Treatment and Pharmacology 14
- Colorectal Cancer Treatments and Studies 11
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Steven M. GrunbergA. MacciocchiCarl A. de MoorHenry HuEileen E. MingLorenzo CohenMichael N. NeussKristen K. McNiff
- Journals
- Journal of Clinical Oncology (30 papers)Cancer Research (6 papers)Cancer (4 papers)Clinical Cancer Research (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Peter D. Eisenberg
79 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 127
- Oncology 2.8k
- Cancer Research 925
- Pulmonary and Respiratory Medicine 1.4k
- Genetics 408
- Anesthesiology and Pain Medicine 199
Countries citing papers authored by Peter D. Eisenberg
This map shows the geographic impact of Peter D. Eisenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Eisenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Eisenberg more than expected).
Fields of papers citing papers by Peter D. Eisenberg
This network shows the impact of papers produced by Peter D. Eisenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Eisenberg. The network helps show where Peter D. Eisenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter D. Eisenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 56 | |
| 2 | 2015 | 4 | |
| 3 | 2014 | 123 | |
| 4 | 2013 | 31 | |
| 5 | 2009 | 48 | |
| 6 | A Phase 2 study of the dual MET/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC). | 2007 | 7 |
| 7 | Safety and tolerability of the anti-IGF-I receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in patients with advanced solid tumors | 2007 | 7 |
| 8 | 2004 | 126 | |
| 9 | 2003 | 327 | |
| 10 | 2003 | 243 | |
| 11 | 2002 | 49 | |
| 12 | 2001 | 22 | |
| 13 | 1998 | 1 | |
| 14 | 1996 | 21 | |
| 15 | 1996 | 21 | |
| 16 | 1995 | 11 | |
| 17 | 1992 | 35 | |
| 18 | 1992 | 34 | |
| 19 | 1990 | 35 | |
| 20 | 1988 | 5 |
About Peter D. Eisenberg
Peter D. Eisenberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gastroenterology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 80 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Nausea and vomiting management (11 papers), Colorectal Cancer Treatments and Studies (11 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Lung Cancer Treatments and Mutations (8 papers), Anesthesia and Pain Management (7 papers), Lung Cancer Research Studies (6 papers) and Pathogenesis and Treatment of Hiccups (6 papers). The work is most often cited by research in Oncology (2.8k citations), Cancer Research (925 citations), Pulmonary and Respiratory Medicine (1.4k citations), Genetics (408 citations) and Anesthesiology and Pain Medicine (199 citations). Peter D. Eisenberg has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Steven M. Grunberg, A. Macciocchi, Carl A. de Moor, Henry Hu, Eileen E. Ming, Lorenzo Cohen, Michael N. Neuss, Kristen K. McNiff, Joseph V. Simone and Joseph O. Jacobson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.